Thilo Schroeder - 22 Sep 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role: Director
Signature: /s/ Darren DeStefano, Attorney-in-Fact
Issuer symbol: PMVP
Transactions as of: 22 Sep 2021
Net transactions value: -$3,000
Form type: 4
Filing time: 24 Sep 2021, 18:59:53 UTC
Previous filing: 21 Sep 2021
Next filing: 29 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMVP	Common Stock	Sale	$3,000	-100	-0.01%	$30.00	1,124,163	22 Sep 2021	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were sold pursuant to a Rule 10b5-1 trading plan.
F2	The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. The Reporting Person is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any.

Content

Shares were sold pursuant to a Rule 10b5-1 trading plan.

The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. The Reporting Person is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any.